Skip to main content

Table 3 The influence of Pro and Raz on primary and metastatic tumor of LLC: PTI (%) – Primary tumor inhibition. MFCPM – metastatic foci count per mouse. Route: ip × 7 every 2 days. Experiment term was 20 days, * P < 0.001(treatment vs vehicle control). The numbers of mice were 30 for both control group and each treatment group. 100 % survival was observed in each group.

From: Antitumor effects of two bisdioxopiperazines against two experimental lung cancer models in vivo

Compounds

Dosage mg/kg/d

Body weigh (g)

PTI(%)

MFCPM

Control

---

22.8/21.4

--

30.9 ± 7.3

Razoxane

20

22.7/21.5

40.3

1.2 ± 0.5*

Probimane

30

23.3/22.5

42.0

1.5 ± 0.5*

Probimane

60

23.3/20.3

48.0

1.0 ± 0.2*